25-Sep-2026
No headlines found.
PRNewswire (Tue, 25-Aug 8:01 AM ET)
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
PRNewswire (Wed, 19-Aug 4:30 PM ET)
SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
PRNewswire (Wed, 12-Aug 4:05 PM ET)
PRNewswire (Wed, 29-Jul 4:05 PM ET)
PRNewswire (Thu, 9-Jul 4:05 PM ET)
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS
PRNewswire (Tue, 30-Jun 4:05 PM ET)
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Sera Prognostics - Class A trades on the NASDAQ stock market under the symbol SERA.
As of September 25, 2026, SERA stock price declined to $2.04 with 12,766 million shares trading.
SERA has a beta of 1.55, meaning it tends to be more sensitive to market movements. SERA has a correlation of 0.07 to the broad based SPY ETF.
SERA has a market cap of $80.48 million. This is considered a Micro Cap stock.
Last quarter Sera Prognostics - Class A reported $30,000 in Revenue and -$.18 earnings per share. This fell short of revenue expectation by $-36,000 and missed earnings estimates by -$.02.
In the last 3 years, SERA traded as high as $12.36 and as low as $1.37.
The top ETF exchange traded funds that SERA belongs to (by Net Assets): VTI, VXF, IWC, BUSM, AVSC.
SERA has underperformed the market in the last year with a price return of -30.8% while the SPY ETF gained +18.4%. However, in the short term, SERA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +13.3% vs +5.3% return in SPY. But in the last 2 weeks, SERA shares have been beat by the market, returning +0.5% compared to an SPY return of +1.2%.
SERA support price is $2.02 and resistance is $2.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SERA shares will trade within this expected range on the day.
